Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 10,127,400 | 10,407,420 | 10,519,070 | 10,365,980 | 10,132,860 |
| Cost of Goods | 2,701,510 | 2,698,250 | 2,829,340 | 2,839,009 | 2,615,100 |
| Gross Profit | 8,093,990 | 8,205,760 | 7,986,260 | 7,643,359 | 7,448,160 |
| Operating Expenses | 5,332,710 | 5,712,530 | 5,435,840 | 6,012,398 | 5,065,390 |
| Operating Income | 2,093,690 | 1,996,890 | 2,254,230 | 1,514,582 | 2,452,471 |
| Interest Expense | 134,090 | 128,190 | 116,820 | 106,720 | 118,180 |
| Other Income | 634,930 | 96,360 | 345,940 | -25,362 | -6,401 |
| Pre-tax Income | 2,594,530 | 1,965,060 | 2,483,350 | 1,382,500 | 2,327,890 |
| Income Tax | 717,180 | 529,950 | 647,040 | 185,140 | -97,560 |
| Net Income Continuous | 1,971,400 | 2,727,500 | 2,825,000 | 2,193,000 | 2,672,767 |
| Net Income | $1,971,400 | $2,727,500 | $2,825,000 | $2,193,000 | $2,672,767 |
| EPS Basic Total Ops | 0.75 | 1.04 | 2.14 | 0.82 | 0.99 |
| EPS Basic Continuous Ops | 0.75 | 1.04 | 2.14 | 0.82 | 0.99 |
| EPS Diluted Total Ops | 0.75 | 1.04 | 2.14 | 0.82 | 0.99 |
| EPS Diluted Continuous Ops | 0.75 | 1.04 | 2.14 | 0.82 | 0.99 |
| EBITDA(a) | $2,093,690 | $1,996,890 | $2,254,230 | $1,514,582 | $2,452,471 |